Company intelligence / Profile preview

Aestura

Seoul, South Korea

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Aestura is a leading South Korean medical beauty company specializing in derma-cosmetics and skin barrier research. Originally established as Pacific Pharmaceutical in 1982, the company rebranded to Aestura to focus on the intersection of dermatology and aesthetics. It is widely recognized for its Atobarrier line, which utilizes patented DermaON technology to mimic the skin's natural lipid structure. In 2021, Aestura was merged into its parent company, Amorepacific, to strengthen its global competitiveness in the medical beauty sector. The brand provides specialized skincare solutions for sensitive skin, atopic dermatitis, and post-procedure recovery, often distributed through hospitals and clinics.

Therapeutic areas: Dermatology
Modalities: Topical formulationSmall molecule
Industry: Non-Drug Biotech

Partnerships

Amorepacific R&I Center

Beyond the preview

Go deeper on Aestura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aestura.

Explore the full profile